Hexindai Inc. - ADR (HX): Price and Financial Metrics
GET POWR RATINGS... FREE!
HX Stock Price Chart Interactive Chart >
HX Price/Volume Stats
|Current price||$2.24||52-week high||$22.39|
|Prev. close||$2.34||52-week low||$1.23|
|Day high||$2.37||Avg. volume||920,478|
|50-day MA||$4.17||Dividend yield||N/A|
|200-day MA||$2.29||Market Cap||36.48M|
Hexindai Inc. - ADR (HX) Company Bio
Hexindai Inc. operates an online consumer lending marketplace connecting borrowers and investors in the People's Republic of China. The company was founded in 2013 and is based in Beijing, China
Most Popular Stories View All
HX Latest News Stream
|Loading, please wait...|
HX Latest Social Stream
View Full HX Social Stream
Latest HX News From Around the Web
Below are the latest news stories about Xiaobai Maimai Inc that investors may wish to consider to help them evaluate HX as an investment opportunity.
Akso Health Group ("Akso Health", the "Company" or "We") (NASDAQ: AHG), formerly known as Xiaobai Maimai Inc., today announced that the Company will update its name and ticker symbol on the Nasdaq Stock Market, effective at the start of trading on December 16, 2021 (the "Effective Date").
Akso Health Group (NASDAQ: AHG) ("Akso Health", the "Company" or "we"), formerly known as Xiaobai Maimai Inc., a social e-commerce platform in China, today announced its unaudited condensed consolidated financial results for the six months ended September 30, 2021.
Xiaobai Maimai Inc. (NASDAQ: HX) ("Xiaobai Maimai" or the "Company"), today announced that it held the 2021 annual general meeting of shareholders (the "AGM") at the Meeting Room, Futian Shangri-La, 4088 Yi Tian Road, Futian District, Shenzhen 518408, People's Republic of China, at 10:00 a.m. (Beijing Time) on December 3, 2021. At the AGM, holders of 71,057,650 ordinary shares (including ordinary shares represented by the Company's American Depositary Shares), out of the 71,478,550 ordinary shar
Xiaobai Maimai Inc. (NASDAQ: HX) ("Xiaobai Maimai," the "Company," or "we"), today announced the appointment of Dr. Yingxian Liu as the medical consultant to the Company. Dr. Liu will work closely with management to develop the Company's cancer therapy and radiation oncology business by the Company's wholly-owned subsidiary, We Health Limited.
I hope you're ready for another busy day of trading because we're starting it with the biggest pre-market stock movers for Wednesday.
HX Price Returns